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In this issue of the Journal, Webb et al. (24) from Toronto 
General Hospital present t t recent contribution toour 
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death has been reported occasionally in non-Asians with 
81990 by the American College of Cardiology 0735~lo97/90/$3.50 
92 MARON 
EDITORIAL COMMENT 
apical hypertrophic cardiomyopathy (!3), it appears to be 
exceedingly uncommon i  these patients. A!tho:Jgh other 
centers have reported patients with the apica! form of 
hypertrophic ardiomyopathy who developed important 
symptoms of functional limitation, the “benign” clinical 
course described by Webb et a!. (24) is, nevertheless, 
consistent with the experience r ported from Japan. 
One of the patients described by Webb et a!. (24) expe- 
rienced an apical myocardia! infarction and the development 
of a discrete apical aneurysm (13) in association with 10~s of 
“giant” T wave negativity and potentially ethal ventricular 
arrhythmias. Although only an anecdotal observation atthis 
time, such a finding suggests an interesting and potentially 
important facet of the natural history of hypertrophic car- 
diomyopathy that may be unique to patients with apical 
hypertropt y.
Relation of apical hypertrophy to the overall population of
hypertrophic cardiomyopathy. There is ample reason to be- 
lieve that apical hypertrophy (in non-Asian patients) does 
not constitute a separate disease ntity, but rather epresents 
a form of nonobstructive hypertrophic cardiomyopathy, and 
is part of the broad clinical and morphologic spectrum of this 
disease (2,3,13,14). Indeed, typical of other forms of hyper- 
trophic ardiomyopathy (29, apical hypertrophic cardiomy- 
opathy may be transmitted genetically, with first degree 
relatives demonstrating either apical or a variety of nonapi- 
ca! patterns of left ventricular hypertrophy (13,14). 
Much of the confusion and disagreement regarding the 
definition and diagnosis of apical hypertrophic cardiomyop- 
athy may be due to differences among investigators and 
institutions with regard to the selection of patients (i.e., 
patterns of patient referral) and also the precise morphologic 
definition of this entity. For example, in its purest morpho- 
logic form, apical hypertrophy is relatively mild in extent 
and is confined to the most distal portion of left ventricle, 
well below papillary muscle level-i.e., similar to the origi- 
nal anatomic description ofapical hypertrophic cardiomyop- 
athy by Sakamoto et al. (7). Consequently, in practical 
terms, the localized hypertrophy insuch patients would be 
imaged by two-dimensional echocardiography only in the 
apical views, and not in the parasteraal short- and long-axis 
planes. On the basis of published ata, as well as my own 
experience, this “pure” morphologic form (“apical hyper- 
trophy of the Japanese type”) would appear to be exceed- 
ing!y rare in non-Asians and, even when observed, it is not 
invariably associated with “giant” T wave inversion (13,14). 
Indeed, most of the cases reported as examples of apica! 
hypertrophic cardiomyopathy from outside Japan (including 
those of Webb et a!. (24)) are characterized by hypertrophy 
that extends, to some degree, beyond the true left ventricu- 
!ar apex and more extensively involves other portions of the 
distal left ventricle and even occasionally small ocalized 
resions of the basal ventricle (13). Because there is no 
standard, precise morphologic definition of “apical hyper- 
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trophic cardiomyopathy,” investigators have natMra!~y dif- 
fered with respect to their perceptions ofthis disease ntity, 
comributing to the confusion regarding its nature, clinical 
significance and relation to the disease spectrum of byper- 
trophic ardiomyopathy. 
Conclusions. The present report of Webb et a!. (24) 
extends the overall clinical experience and knowledge of 
apical hypertrophic cardiomyopathy in non-Asian patients, 
particularly with respect to the natural history of this 
entity. The authors’ findings emphasize that many, but not 
al!, patients constituting this rare subset within the disease 
spectrum of hypertrophic cardiomyopathy experience a be- 
nign clinical course and may remain in relatively stable 
condition without symptoms for long periods of time. 
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